Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea · Delayed Price · Currency is KRW 61,300
+1,100 (1.83%)
At close: Mar 20, 2026
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 2.67 trillion as of March 20, 2026. Its market cap has increased by 16.97% in one year.
Market Cap
2.67T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
105.08
Stock Price
61,300.00
Market Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.67T, an increase of 3,917.25%. That is a compound annual growth rate of 20.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.67T | 3.61% |
| Dec 30, 2025 | 2.57T | 4.33% |
| Dec 30, 2024 | 2.47T | -35.41% |
| Dec 28, 2023 | 3.82T | 44.48% |
| Dec 29, 2022 | 2.64T | -43.45% |
| Dec 30, 2021 | 4.67T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 7.45T |
| Hanmi Pharm. | 6.58T |
| Hanall Biopharma | 2.87T |
| Daewoong Pharmaceutical | 1.84T |
| GC Biopharma | 1.68T |
| Chong Kun Dang Pharmaceutical | 1.17T |
| Daewoong | 1.01T |
| Ildong Pharmaceutical | 986.20B |